Treatment of Splenic Vein Thrombosis in Liver Cirrhosis

This protocol covers symptomatic acute splanchnic vein thrombosis occurring in the context of liver cirrhosis — a setting where the underlying liver disease is a central determinant of both thrombosis risk and the management approach.

Liver cirrhosis is the defining comorbidity in this scenario. The severity of liver dysfunction is the key factor that guides which therapeutic agents are appropriate and whether certain options are contraindicated. Management decisions cannot be separated from the patient's degree of hepatic impairment.

Anticoagulant therapy is the primary intervention in this setting, with agent selection tailored to the severity of liver dysfunction. The full protocol details the sequencing, criteria for extended treatment, and the specific situations that call for a longer or indefinite course.